glp 1 etfs New Year's Resolutions: Lose Weight & Allocate to GLP-1 The next phase of the

Newer agents appear to be more effective at A1c and weight lowering, and its a very exciting time for the treatment of type 2 diabetes and obesity when the new GLP-1 agonists are able to achieve more robust A1c lowering than any other existing diabetes medication other than insulin, she told Healthline

In the case of semaglutide, it's posited that the medication's effectiveness in reducing appetite and promoting weight loss could inadvertently lead to amenorrhea

In Quebec, where one in four adults is obese, the current cost of these new drugs (approximately $500 per month) would involve an annual expenditure of several hundred million dollars (in the United States the situation is even worse: the cost of a 72-week course of tirzepatide (15 mg/week) is approximately US$17,000, while the 68-week treatment with semaglutide (2.4 mg/week) is nearly US$23,000!)

Wong, K

Key Takeaway: Ozempic was never intended to be taken at a 3mg dose